Updated:
Korion Life Sciences
Korion Life Sciences is a Madrid-based venture capital firm that manages a venture capital fund of funds focused on the life sciences sector.
Korion Life Sciences
Korion Life Sciences is a Madrid-based venture capital firm that manages a venture capital fund of funds focused on the life sciences sector. The firm invests in top-tier life sciences venture capital firms across three key verticals: biotech/biopharma, MedTech, and computational healthcare. Its investment strategy targets opportunities spanning the United States, Europe, and Israel, covering companies at seed, early-stage, and late-stage development phases. Korion serves both institutional and individual investors, providing diversified access to high-performing and socially impactful funds. The firm operates through a regulated vehicle, offering investors structured exposure to the life sciences venture ecosystem. By deploying a fund-of-funds approach, Korion enables its investors to access premium life sciences venture capital managers across multiple geographies and stages.
General information
Firm type
Venture Capital
Location
Region
Europe
Country
Spain
City
Madrid
Corporate office
Madrid, Spain
Sector focus
Frequently asked questions
What type of investment firm is Korion Life Sciences?
Korion Life Sciences is a venture capital firm based in Madrid, Spain, that manages a venture capital fund of funds investing in top-tier life sciences venture capital firms.
What sectors does Korion Life Sciences focus on?
The firm focuses on three life sciences verticals: biotech/biopharma, MedTech, and computational healthcare.
What geographies and stages does Korion Life Sciences target?
Korion targets opportunities in the United States, Europe, and Israel at seed, early-stage, and late-stage development phases.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: